Immunotherapy of insulin-dependent diabetes mellitus
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 13 (5) , 601-605
- https://doi.org/10.1016/s0952-7915(00)00267-3
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transferGene Therapy, 2000
- Biolistic-Mediated Interleukin 4 Gene Transfer Prevents the Onset of Type 1 DiabetesHuman Gene Therapy, 2000
- Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study.Diabetes Care, 1999
- Systemic Delivery of Interleukin 10 by Intramuscular Injection of Expression Plasmid DNA Prevents Autoimmune Diabetes in Nonobese Diabetic MiceHuman Gene Therapy, 1998
- Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetesEuropean Journal of Immunology, 1997
- Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.Journal of Clinical Investigation, 1996
- Peptide therapy for diabetes in NOD miceThe Lancet, 1994
- Altered Cytokine Activity in Adjuvant Inhibition of Autoimmune DiabetesJournal of Autoimmunity, 1993
- Prevention of diabetes in NOD mice treated with antibody to murine IFNγJournal of Autoimmunity, 1991
- The involvement of Ly 2+ T cells in beta cell destructionJournal of Autoimmunity, 1990